Number of shares outstanding for Esperion Therapeutics (ESPR)

Number of shares outstanding as of September 2024 : 188,793,816

According to Esperion Therapeutics's latest financial reports and stock price the company's current number of shares outstanding is 188,793,816. At the end of 2024 the company had 188,793,816 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.

Shares outstanding history for Esperion Therapeutics from 2000 to 2024

Shares Outstanding at the end of each year

Year	Shares Outstanding	Change
2024	0.18 B	67.96%
2023	0.11 B	52.96%
2022	73.48 M	99.45%
2021	36.84 M	37.06%
2020	26.88 M	-1.78%
2019	27.37 M	2.06%
2018	26.81 M	2.27%
2017	26.22 M	16.26%
2016	22.55 M	0.17%
2015	22.51 M	16.8%
2014	19.27 M	25.7%
2013	15.33 M	2022.53%
2012	0.72 M
2003	4.63 M	10.61%
2002	4.18 M	3.87%
2001	4.03 M	92.06%
2000	2.09 M

Shares Outstanding for similar companies or competitors

Company	Shares Outstanding	differencediff.	Country
Ultragenyx RARE	84,286,292	-55.36%	🇺🇸 USA
BioMarin Pharmaceutical BMRN	190,114,000	0.70%	🇺🇸 USA
Pfizer PFE	5,666,000,000	2,901.16%	🇺🇸 USA
Regeneron Pharmaceuticals REGN	108,100,000	-42.74%	🇺🇸 USA
Amicus Therapeutics FOLD	303,773,922	60.90%	🇺🇸 USA
Lexicon Pharmaceuticals LXRX	245,390,000	29.98%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is receiving financial compensation for Delta App installs.
CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions